* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Dr Martin Walker - Imperial College London
Survey
Document related concepts
Transcript
Dr Martin Walker [email protected] Qualifications 2006-2010 2004-2005 2001-2004 PhD Infectious Disease Epidemiology, Imperial College London The Population Biology of Ascaris lumbricoides infections in human MSc Control of Infectious Diseases, London School of Hygiene & Topical Medicine BA Biological Sciences, University of Oxford Employment 2010-present Research Associate, Department of Infectious Disease Epidemiology, Imperial College London Conduct quantitative epidemiological research on the control and elimination of neglected tropical and parasitic diseases; to date, I have published 30 peerreviewed publications and a book chapter. Develop and write innovative research proposals; since 2015, I have secured funds totalling US$241,000. Coordinate activities of a research group comprising Research Assistants; PhD; MRes; MSc and University Research Opportunities Programme (UROP) students. Establish a network of collaborators in academic and industrial sectors including international research consortia and non-for-profit pharmaceutical companies. Disseminate research findings at national and international conferences and deliver research-based policy advice to public health agencies. Grants and awards 2013-present 2016 2015 Honorary Lecturer, The Ear Institute, University College London Principal Investigator Mathematical modelling of novel macrofilaricidal drugs for river blindness: from patients to populations. Drugs for Neglected Diseases initiative (DNDi). Principal Investigator Evaluating variation among anthelmintic drug response to support the control and elimination of human helminthes. World Health Organization. $100,593 $140,407 Teaching and supervision Undergraduate and graduate teaching 2012-present Lecturer on the modules: Vector Borne Infections and Helminth Epidemiology and Control and Further Infectious Disease Epidemiology; MSc Epidemiology, Imperial College London. 2012-present Lecturer and practical organiser on Epidemiology module; BSc Biology, Imperial College London. 2013 Invited Lecturer on Vectors of Filarial Disease; Diploma in Tropical Medicine & Hygiene, London School of Hygiene & Tropical Medicine. Student supervision 2013-present Co-supervisor of two PhD students at Imperial College London and University College London. 2012-present Supervisor and co-supervisor of two five-month MRes research projects and seven MSc dissertations. Two distinctions; two subsequent PhD scholarships awarded. Short courses and capacity building 2014-present Lecturer and project co-coordinator (vector-borne diseases) for the short course for public health professionals: Epidemiology and Control of Infectious Disease, Imperial College London. 2012-2013 Lecturer and co-organiser of the Short Courses: Introduction to Data Analysis for Neglected Tropical Diseases using R and Writing and Grantsmanship Skills for Research in Neglected Tropical Diseases, Royal Society–Leverhulme Trust Capacity Building Africa Award, Noguchi Memorial Institute for Medical Research, University of Ghana, Legon, Ghana. Martin Walker 2 Evidence of esteem Invited talks 2016 Optimising macrofilaricidal drug trial design using clinical trial simulators. DNDi Onchocerciasis Clinical and Regulatory Technical meeting. Geneva, Switzerland. 2016 Mathematical modelling to support the control and elimination of neglected tropical diseases: from patients to populations. Royal Veterinary College, Hatfield, UK 2016 Modelling onchocerciasis elimination. 55th Mectizan Expert Committee Meeting. The Mectizan Donation Program, Task Force for Global Health, Atlanta, Georgia, USA 2015 Modelling parasitological responses of childhood schistosome infections to treatment with praziquantel. Schistosomiasis Data Platform Stakeholders Meeting. Geneva, Switzerland 2015 Mathematical models for assessing the efficacy of anti-Onchocerca drugs. DNDi Clinical Expert Meeting on Onchocerciasis. Geneva, Switzerland 2015 Alternative treatment strategies for accelerating elimination of onchocerciasis in Africa. African Programme for Onchocerciasis Control 2nd meeting on alternative treatment strategies. Ouagadougou, Burkina Faso 2014 Modelling new interventions for the control of onchocerciasis. Institute of Infection & Global Health Seminar Series. University of Liverpool, Liverpool, UK 2014 Potential long-term epidemiological consequences of a vaccination programme against onchocerciasis. 38th session of the Technical Consultative Committee of the African Programme for Onchocerciasis Control. Ouagadougou, Burkina Faso 2012 Insights from mathematical modelling for monitoring and evaluation. 13th International Symposium on Schistosomiasis, Belo Horizonte, Minas Gerais, Brazil Editorial and review activities 2015-present Editorial board member of Acta Tropica 2013-present Reviewer of grant applications for the Wellcome Trust, the Coalition for Operational Research on Neglected Tropical Diseases (COR-NTD) and the NTD Modelling Consortium. 2011-present Reviewer of research papers for journals including: Advances in Parasitology; Emerging Infectious Diseases; Journal of the Royal Society Interface; Lancet Global Health; PLoS Neglected Tropical Diseases and Veterinary Parasitology. Membership of professional bodies 2014-present 2008-present 2008-present Fellow of the Royal Statistical Society American Society of Tropical Medicine and Hygiene British Society for Parasitology Selected recent publications† 1. Crellen R*, Walker M*, Lamberton PHL, Kabatereine NB, Tukahebwa EM, Cotton JA, Webster JP. Reduced efficacy of praziquantel against Schistosoma mansoni associated with multiplerounds of mass drug administration. Clin Infect Dis in press. 2. Frempong KF*, Walker M*, Cheke RA, Tetwvi EJ, Gyan ET, Wilson MD, Boakye DA, Taylor MJ, Biritwum NK, Osei-Atweneboana MY, Basáñez MG. Does increasing treatment frequency address sub-optimal responses to ivermectin for the control and elimination of river blindness? Clin Infect Dis 2016 62:1338-1347. 3. Walker M*, Mabud T*, Olliaro PL, Coulibaly JT, King CH, Raso G, Scherrer AU, Stothard JR, Sousa-Figueiredo JC, Stete K, Utzinger J, Basáñez MG. New approaches to measuring anthelminthic drug efficacy: parasitological responses of childhood schistosome infections to treatment with praziquantel. Parasit Vectors 2016; 9:41 4. Walker M, Specht S, Churcher TS, Hoerauf A, Taylor MJ, Basáñez MG. The therapeutic efficacy and macrofilaricidal activity of doxycycline for the treatment of river blindness. Clin Infect Dis 2015; 60:1199-1207. 5. Walker M, Churcher TS, Basáñez MG. Models for measuring anthelmintic drug efficacy for parasitologists. Trends Parasitol 2014; 30:528-537. † a complete list of publications is available in the Appendix * contributed equally